secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0001193125-22-301791
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera receives Nasdaq delisting notice for failing to meet $50M MVLS; plans appeal
--------------------------------------------------------------------------------

- Nasdaq notified Galera on Dec 6, 2022 of failure to regain compliance with $50M MVLS requirement by Dec 5 deadline.
- Trading suspension and delisting from Nasdaq Global Market scheduled for Dec 15 unless hearing requested by Dec 13.
- Company will request a hearing to appeal; request will stay suspension pending Panel decision.
- May seek transfer to Nasdaq Capital Market if Global Market listing is not continued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312522301791/0001193125-22-301791-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312522301791/d414316d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-301791

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer